Company intelligence / Profile preview
Alessa Therapeutics
San Carlos, California, United Statesalessatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Alessa has initiated first-in-human Phase I studies of its Enolen® implant for localized sustained delivery of enzalutamide in prostate cancer patients. Early feasibility testing with the Biolen® system has been completed. The company’s approach aims to deliver anti-androgen therapy directly to the prostate, potentially reducing systemic side effects seen with current therapies. Initial data from ongoing trials are expected soon.[3][5][10]
- Therapeutic areas
- Men's HealthOncology
- Modalities
- Drug-eluting implants (localized sustained drug delivery)Small molecules (anti-androgens such as enzalutamide and bicalutamide)[1][3][7]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
National Cancer Institute / NIH – collaboration on clinical studies including first-in-human trial of Enolen and Biolen systems[5][9]Johnson & Johnson Innovation – JJDC, Inc. – investor and board representation through venture arm participation[3]
Beyond the preview
Go deeper on Alessa Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alessa Therapeutics.